{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:25:10Z","timestamp":1787739910185,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Amiodarone-induced thyroid dysfunction (AIT) is a side-effect associated with the use of Amiodarone for the treatment of refractory arrythmias. Resulting hyperthyroidism can precipitate cardiac complications, including cardiac ischemia and myocardial infarction, although this has only been described in a few case reports.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present here a clinical scenario involving a 66-year-old male Caucasian patient under Amiodarone for atrial fibrillation, who developed AIT. In the presence of dyspnea, multiple cardiovascular risk factors and ECG abnormalities, a transthoracic echocardiogram was performed, showing inferobasal hypokinesia. This led to further investigations through a cardiac PET-CT, where cardiac ischemia was suspected. Ultimately, the coronary angiography revealed no abnormalities. Nonetheless, these extensive cardiologic investigations led to a delay in initiating an emergency endovascular revascularization for acute-on-chronic left limb ischemia. Although initial treatment using Carbimazole was not successful after three weeks, the patient reached euthyroidism after completion of the treatment with Prednisone so that eventually thyroidectomy was not performed. Endovascular revascularization was finally performed after more than one month.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We discuss here cardiac abnormalities in patients with AIT, which may be due to relative ischemia secondary to increased metabolic demand during hyperthyroidism. Improvement of cardiac complications is expected through an optimal AIT therapy including medical therapy as the primary approach and, when necessary, thyroidectomy. Cardiac investigations in the context of AIT should be carefully considered and may not justify delaying other crucial interventions. If considered mandatory, diagnostic procedures such as coronary angiography should be preferred to functional testing.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-024-04552-w","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T11:01:54Z","timestamp":1714647714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac evaluation in amiodarone-induced thyroid dysfunction with suspected cardiac ischemia?: a case report and review of the literature"],"prefix":"10.1186","volume":"18","author":[{"given":"Yoann","family":"Aubry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Dosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Y.","family":"Donath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"4552_CR1","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","volume":"298","author":"P Vassallo","year":"2007","unstructured":"Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007;298:1312\u201322.","journal-title":"JAMA"},{"key":"4552_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/edrv.22.2.0427","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid*. Endocr Rev. 2001;22:240\u201354. https:\/\/doi.org\/10.1210\/edrv.22.2.0427.","journal-title":"Endocr Rev"},{"key":"4552_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/JCEM.86.1.7119","volume":"86","author":"GH Daniels","year":"2001","unstructured":"Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2001;86:3\u20138. https:\/\/doi.org\/10.1210\/JCEM.86.1.7119.","journal-title":"J Clin Endocrinol Metab"},{"key":"4552_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","volume":"69","author":"ML Tanda","year":"2008","unstructured":"Tanda ML, Piantanida E, Lai A, et al. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf). 2008;69:812\u20138. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03268.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4552_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","volume":"61","author":"L Bartalena","year":"2004","unstructured":"Bartalena L, Wiersinga WM, Tanda ML, et al. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Clin Endocrinol (Oxf). 2004;61:494\u2013502. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02119.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4552_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.14740\/jmc3473","volume":"11","author":"B Ataallah","year":"2020","unstructured":"Ataallah B, Buttar B, Kaell A, et al. Coronary vasospasm-induced myocardial infarction: an uncommon presentation of unrecognized hyperthyroidism. J Med Cases. 2020;11:140\u20131. https:\/\/doi.org\/10.14740\/jmc3473.","journal-title":"J Med Cases"},{"key":"4552_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00019501-200505000-00001","volume":"16","author":"YH Choi","year":"2005","unstructured":"Choi YH, Jae HC, Sung WB, et al. Severe coronary artery spasm can be associated with hyperthyroidism. Coron Artery Dis. 2005;16:135\u20139. https:\/\/doi.org\/10.1097\/00019501-200505000-00001.","journal-title":"Coron Artery Dis"},{"key":"4552_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3724\/SP.J.1263.2011.00258","volume":"8","author":"XH Kuang","year":"2011","unstructured":"Kuang XH, Zhang SY. Hyperthyroidism-associated coronary spasm: a case of non-ST segment elevation myocardial infarction with thyrotoxicosis. J Geriatr Cardiol. 2011;8:258\u20139. https:\/\/doi.org\/10.3724\/SP.J.1263.2011.00258.","journal-title":"J Geriatr Cardiol"},{"key":"4552_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.poamed.2015.03.007","volume":"22","author":"E Malarkiewicz","year":"2015","unstructured":"Malarkiewicz E, Dziama\u0142ek PA, Konsek SJ. Myocardial infarction as a first clinical manifestation of hyperthyroidism. Polish Ann Med. 2015;22:139\u201342. https:\/\/doi.org\/10.1016\/j.poamed.2015.03.007.","journal-title":"Polish Ann Med"},{"key":"4552_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/clc.4960230417","volume":"23","author":"N Pereira","year":"2000","unstructured":"Pereira N, Parisi A, Dec GW, et al. Myocardial stunning in hyperthyroidism. Clin Cardiol. 2000;23:298\u2013300. https:\/\/doi.org\/10.1002\/clc.4960230417.","journal-title":"Clin Cardiol"},{"key":"4552_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0167-5273(02)00524-7","volume":"90","author":"RM Gowda","year":"2003","unstructured":"Gowda RM, Khan IA, Soodini G, et al. Acute myocardial infarction with normal coronary arteries associated with iatrogenic hyperthyroidism. Int J Cardiol. 2003;90:327\u20139.","journal-title":"Int J Cardiol"},{"key":"4552_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/thy.1995.5.465","volume":"5","author":"GJ Locker","year":"1995","unstructured":"Locker GJ, Kotzmann H, Frey B, et al. Factitious hyperthyroidism causing acute myocardial infarction. Thyroid. 1995;5:465\u20137. https:\/\/doi.org\/10.1089\/thy.1995.5.465.","journal-title":"Thyroid"},{"key":"4552_CR13","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1210\/jc.2006-2644","volume":"92","author":"M Homoncik","year":"2007","unstructured":"Homoncik M, Gessl A, Ferlitsch A, et al. Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 2007;92:3006\u201312. https:\/\/doi.org\/10.1210\/jc.2006-2644.","journal-title":"J Clin Endocrinol Metab"},{"key":"4552_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2265.2006.02464.x","volume":"64","author":"C Erem","year":"2006","unstructured":"Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf). 2006;64:323\u20139. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02464.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4552_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-16-0576","volume":"176","author":"OM Dekkers","year":"2017","unstructured":"Dekkers OM, Horv\u00e1th-Puh\u00f3 E, Cannegieter SC, et al. Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study. Eur J Endocrinol. 2017;176:1\u20139. https:\/\/doi.org\/10.1530\/EJE-16-0576.","journal-title":"Eur J Endocrinol"},{"key":"4552_CR16","first-page":"2330","volume":"64","author":"N Takasu","year":"2006","unstructured":"Takasu N. Thyroid hormone and the cardiovascular system. Nippon rinsho. Japanese J Clin Med. 2006;64:2330\u20138.","journal-title":"Japanese J Clin Med"},{"key":"4552_CR17","first-page":"45","volume-title":"Experimental and clinical endocrinology and diabetes","author":"RM Kaderli","year":"2015","unstructured":"Kaderli RM, Fahrner R, Christ ER, et al. Total thyroidectomy for amiodarone-induced thyrotoxicosis in the hyperthyroid state. In: Experimental and clinical endocrinology and diabetes. Germany: Georg Thieme Verlag; 2015. p. 45\u20138."},{"key":"4552_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1210\/clinem\/dgz041","volume":"105","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Papini P, Pingitore A, et al. Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2020;105:242\u201351. https:\/\/doi.org\/10.1210\/clinem\/dgz041.","journal-title":"J Clin Endocrinol Metab"},{"key":"4552_CR19","doi-asserted-by":"publisher","first-page":"E3427","DOI":"10.1210\/clinem\/dgaa464","volume":"105","author":"D Cappellani","year":"2020","unstructured":"Cappellani D, Papini P, Di Certo agostino M, et al. Duration of exposure to thyrotoxicosis increases mortality of compromised AIT patients: the role of early thyroidectomy. J Clin Endocrinol Metab. 2020;105:E3427\u201336. https:\/\/doi.org\/10.1210\/clinem\/dgaa464.","journal-title":"J Clin Endocrinol Metab"},{"key":"4552_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1210\/js.2018-00259","volume":"2","author":"A Kotwal","year":"2018","unstructured":"Kotwal A, Clark J, Lyden M, et al. Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience. J Endocr Soc. 2018;2:1226\u201335. https:\/\/doi.org\/10.1210\/js.2018-00259.","journal-title":"J Endocr Soc"},{"key":"4552_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.17925\/ee.2023.19.1.78","volume":"19","author":"JE Quiroz-Aldave","year":"2023","unstructured":"Quiroz-Aldave JE, Durand-V\u00e1squez MC, Lobato-Jeri CJ, et al. Thyrotoxic cardiomyopathy: state of the art. Eur Endocrinol. 2023;19:78. https:\/\/doi.org\/10.17925\/ee.2023.19.1.78.","journal-title":"Eur Endocrinol"},{"key":"4552_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1536\/ihj.48.107","volume":"48","author":"K Oe","year":"2007","unstructured":"Oe K, Yamagata T, Mori K. Acute myocardial infarction following hormone replacement in hypothyroidism. Int Heart J. 2007;48:107\u201311. https:\/\/doi.org\/10.1536\/ihj.48.107.","journal-title":"Int Heart J"},{"key":"4552_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.4158\/EP.14.9.1137","volume":"14","author":"TA Kassim","year":"2008","unstructured":"Kassim TA, Clarke DD, Mai VQ, et al. Catecholamine-induced cardiomyopathy. Endocr Pract. 2008;14:1137\u201349.","journal-title":"Endocr Pract"},{"key":"4552_CR24","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cjca.2017.07.002","volume":"33","author":"C Beyer","year":"2017","unstructured":"Beyer C, Plank F, Friedrich G, et al. Effects of hyperthyroidism on coronary artery disease: a computed tomography angiography study. Can J Cardiol. 2017;33:1327\u201334. https:\/\/doi.org\/10.1016\/j.cjca.2017.07.002.","journal-title":"Can J Cardiol"},{"key":"4552_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s1607-551x(09)70273-6","volume":"21","author":"TH Lin","year":"2005","unstructured":"Lin TH, Su HM, Voon WC, et al. Unstable angina with normal coronary angiography in hyperthyroidism: a case report. Kaohsiung J Med Sci. 2005;21:29\u201333. https:\/\/doi.org\/10.1016\/s1607-551x(09)70273-6.","journal-title":"Kaohsiung J Med Sci"},{"key":"4552_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000486957","volume":"7","author":"L Bartalena","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L, et al. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018;7:55\u201366.","journal-title":"Eur Thyroid J"},{"key":"4552_CR27","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00268-005-0673-x","volume":"30","author":"J Gough","year":"2006","unstructured":"Gough J, Gough IR. Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg. 2006;30:1957\u201361.","journal-title":"World J Surg"},{"key":"4552_CR28","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1210\/jc.2012-1797","volume":"97","author":"L Tomisti","year":"2012","unstructured":"Tomisti L, Materazzi G, Bartalena L, et al. Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. J Clin Endocrinol Metab. 2012;97:3515\u201321. https:\/\/doi.org\/10.1210\/jc.2012-1797.","journal-title":"J Clin Endocrinol Metab"},{"key":"4552_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00106-013-2806-0","volume":"62","author":"C Meerwein","year":"2014","unstructured":"Meerwein C, Vital D, Greutmann M, et al. Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery? HNO. 2014;62:100\u20135.","journal-title":"HNO"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04552-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T11:05:31Z","timestamp":1714647931000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04552-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4552"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04552-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. The content of the manuscript has not been published, or been submitted for publication elsewhere.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}